HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Banana Boat Brand Building Planned Under Playtex Realignment

This article was originally published in The Rose Sheet

Executive Summary

Playtex plans to strengthen its Banana Boat sun care franchise by launching innovative products and new advertising initiatives, as well as improving relationships with retailers, President and CEO Neil DeFeo reported during an April 5 investor meeting outlining the company's realignment plan

You may also be interested in...



Playtex Realignment Expected To Yield Savings Of $22 Mil.-$24 Mil.

Playtex expects to generate cost savings of $12 mil.-$14 mil. in 2005 from a business realignment, with fully annualized savings of $22 mil.-$24 mil. to be realized in 2006, the company reported Feb. 8. The cash generated from the realignment will be used to reinvest in brands and pay down debt

Banana Boat Sails Into Summer With Sunless Tanning Launch

Playtex will support the launch of Banana Boat Summer Color sunless tanning products with TV and print ads breaking in April, the company said during a Jan. 19 press event in New York City unveiling its 2005 sun care lineup

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel